Literature DB >> 2167985

Antitumor agents. 113. New 4 beta-arylamino derivatives of 4'-O-demethylepipodophyllotoxin and related compounds as potent inhibitors of human DNA topoisomerase II.

Z Q Wang1, Y H Kuo, D Schnur, J P Bowen, S Y Liu, F S Han, J Y Chang, Y C Cheng, K H Lee.   

Abstract

A number of 4'-O-demethylepipodophyllotoxin derivatives possessing various 4 beta-N-, 4 beta-O- or 4 beta-S-aromatic rings have been synthesized and evaluated for their inhibitory activity against the human DNA topoisomerase II as well as for their activity in causing cellular protein-linked DNA breakage. The results indicated, that for DNA topoisomerase II, a basic unsubstituted 4 beta-anilino moiety is structurally required for the enhanced activity. Substitution on this moiety with CN, COOCH3, COOC2H5, OH and COOCH3, OCH3, COCH3, CH2OH, OCH2O, OCH2CH2O, phenoxy, morpholino, NO2, and NH2 either at the para and/or the meta position yielded compounds which are as potent or more potent than etoposide. Substitution with COOC2H5 and OH at the ortho position afforded inactive compounds. Replacement of the aryl nitrogen with oxygen or sulfur gave compounds which are much less active or inactive. However, replacement of the phenyl ring with a pyridine nucleus furnished compounds which are as active or slightly more active than etoposide. There is a lack of correlation between the ability of these compounds in inhibiting DNA topoisomerase II and in causing protein-linked DNA breaks.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2167985     DOI: 10.1021/jm00171a050

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  16 in total

Review 1.  Strategies for the Optimization of Natural Leads to Anticancer Drugs or Drug Candidates.

Authors:  Zhiyan Xiao; Susan L Morris-Natschke; Kuo-Hsiung Lee
Journal:  Med Res Rev       Date:  2015-09-11       Impact factor: 12.944

Review 2.  Plant-derived natural product research aimed at new drug discovery.

Authors:  Hideji Itokawa; Susan L Morris-Natschke; Toshiyuki Akiyama; Kuo-Hsiung Lee
Journal:  J Nat Med       Date:  2008-04-22       Impact factor: 2.343

3.  A novel podophyllotoxin-derived compound GL331 is more potent than its congener VP-16 in killing refractory cancer cells.

Authors:  T S Huang; C C Lee; Y Chao; C H Shu; L T Chen; L L Chen; M H Chen; C C Yuan; J Whang-Peng
Journal:  Pharm Res       Date:  1999-07       Impact factor: 4.200

Review 4.  Discovery and development of natural product-derived chemotherapeutic agents based on a medicinal chemistry approach.

Authors:  Kuo-Hsiung Lee
Journal:  J Nat Prod       Date:  2010-03-26       Impact factor: 4.050

5.  Design, synthesis, and cytotoxicity of perbutyrylated glycosides of 4β-triazolopodophyllotoxin derivatives.

Authors:  Cheng-Ting Zi; Zhen-Hua Liu; Gen-Tao Li; Yan Li; Jun Zhou; Zhong-Tao Ding; Jiang-Miao Hu; Zi-Hua Jiang
Journal:  Molecules       Date:  2015-02-16       Impact factor: 4.411

6.  A novel topoisomerase II poison GL331 preferentially induces DNA cleavage at (C/G)T sites and can cause telomere DNA damage.

Authors:  C C Lee; T S Huang
Journal:  Pharm Res       Date:  2001-06       Impact factor: 4.200

7.  Design, synthesis and cytotoxic activity of novel sulfonylurea derivatives of podophyllotoxin.

Authors:  Zhi-Jun Zhang; Jing Tian; Li-Ting Wang; Mei-Juan Wang; Xiang Nan; Liu Yang; Ying-Qian Liu; Susan L Morris-Natschke; Kuo-Hsiung Lee
Journal:  Bioorg Med Chem       Date:  2013-11-28       Impact factor: 3.641

8.  Synthesis of Novel Functionalized 4-Aza-2,3-Didehydropodophyllotoxin Derivatives with Potential Antitumor Activity.

Authors:  Ajay Kumar; Antonio E Alegria
Journal:  J Heterocycl Chem       Date:  2010-11       Impact factor: 2.193

9.  Antitumor agents. 126. Novel 4 beta-substituted anilino derivatives of 3',4'-O,O-didemethylpodophyllotoxin as potent inhibitors of human DNA topoisomerase II.

Authors:  Z Q Wang; Y C Shen; H X Chen; J Y Chang; X Guo; Y C Cheng; K H Lee
Journal:  Pharm Res       Date:  1993-03       Impact factor: 4.200

10.  Antitumor agents. 125. New 4 beta-benzoylamino derivatives of 4'-O-demethyl-4-desoxypodophyllotoxin and 4 beta-benzoyl derivatives of 4'-O-demethylpodophyllotoxin as potent inhibitors of human DNA topoisomerase II.

Authors:  X M Zhou; Z Q Wang; H X Chen; Y C Cheng; K H Lee
Journal:  Pharm Res       Date:  1993-02       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.